Back to Find a Doctor
Jonathan Colasanti

Jonathan A. Colasanti, MD, MSPH

Associate Medical Director Infectious Disease Program

Jonathan Colasanti, MD, MSPH is an Assistant Professor of Medicine (Infectious Diseases) and Global Health (Rollins School of Public Health) at Emory University in Atlanta, Georgia. He completed medical school and a Master’s in Public Health at the University of Miami. He completed his Internal Medicine and Global Health Residency at the University of Miami and his Infectious Diseases fellowship at Emory University.
Jonathan developed a passion for HIV in high school and has dedicated himself to the field ever since. He has experience treating PLHIV in Miami, Atlanta, Peru, Nicaragua and Ethiopia, giving him a global perspective of HIV treatment and care. His clinical and research interests focus on the delivery of HIV care to vulnerable populations, across the spectrum of the HIV care continuum. In his research, he seeks to bridge the implementation gap in order to improve the delivery of HIV care, by addressing socio-behavioral, biomedical, and systems-level barriers. In addition to his Atlanta-based work, he serves on the U.S. advisory board for a Nicaraguan NGO that strives to improve the delivery of primary health care in Nicaragua through a community health worker model.

Specialties

  • Infectious Disease
  • Internal Medicine

Board Certifications

  • ABMS Internal Medicine

Fellowships

  • Emory University School of Medicine

Affiliations

  • Emory

Education & Training

  • Medical School: University of Miami Miller
  • Internship: University of Miami-Jackson Memorial Hospital
  • Residency: University of Miami-Jackson Memorial Hospital

Honors & Awards

2001 Phi Eta Sigma National Honor Society, University of Virginia

2002 Golden Key National Honor Society, University of Virginia

2003 National Society of Collegiate Scholars, University of Virginia

2008 Eric Reiss Outstanding Student in Medicine, University of Miami

2008 Alpha Omega Alpha Honor Medical Society, University of Miami

2009 Housestaff Most Dedicated to Ambulatory Medicine, University of Miami

2011 FACP Outstanding Resident of the Year, Internal Medicine, University of Miami

2012 Delta Omega Public Health Honor Society, University of Miami

2014 Emory Department of Medicine clinical research poster award: 2nd place

2014 CROI 2015 Young Investigator Scholarship

2016 Outstanding Clinical Scientific Citation Award (Junior Faculty), Emory Department of Medicine

2016 Grady Top Doc

2017 Featured Caregiver at the Grady Health System

2017 White Coat Grady Gala

2017 Nanette K. Wenger Distinguished Service Award, Emory Department of Medicine (Assistant Professor level)

2017 Faculty of Excellence, Emory School of Medicine (for patient satisfaction scores)

Publications

Choudhary S, Choudhary N, Kimbrell K, Colasanti J, Ziogas A, Kwa D, Camerini D. R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces cytokine and CCR5 Expression. J Virol. 2005; 79: 458 – 471. PMID 15596839

Colasanti J, Nguyen L, Tjin Kon Kiem J, Deeb K, Jayaweera D. Disparities in HIV-treatment Responses between Haitian, African Americans, and Hispanics Living in Miami-Dade County Florida. J Health Care Poor Underserved. 2012; 23: 179 – 190. PMID 22643470

Colasanti J, Altamirano J, Espinoza L. An unwelcome synergy: Leishmaniasis and HIV. The Am J Med. 2013;126(2):114-116. PMID 23331437

Colasanti J, Lorio Rugama M, Lifschitz K, Largaespada M, Flores-Lopéz B, Dodd C, et al. HIV testing rates among pregnant women in Managua, Nicaragua, 2010-2011. Rev Panam Salud Publica. 2013;33(1):15-21. PMID 23440153

Colasanti J, Marconi V & Babafemi T. Antiretroviral reduction: is it time to rethink the unthinkable? AIDS. 2014 Apr 24;28(7):943-7. PMID 24401641

Colasanti J, Armstrong W. A portal to the early years of the HIV epidemic – A fellow’s viewpoint in 2014. Open Forum Infec Diseases. 2014 Summer;1(2). 1 – 3. PMID 25734112

Lorío M, Colasanti J, Moreira S, Gutierrez G, Quant C. Adverse drug reactions to antiretroviral therapy in HIV-infected patients at the largest public hospital in Nicaragua. J Int Assoc Provid AIDS Care. 2014 Sep;13(5):466-70. PMID 24935691

Colasanti J, McDaniel D, Johnson B, del Rio C, Sunpath H. Marconi V. Novel Predictors of Poor Retention Following a Down-referral from a Hospital-based ART Program in South Africa. AIDS Res Hum Retroviruses. 2016 Apr;32(4):357-63 PMID 26559521.

Colasanti J, Kelly J, Pennisi E, Hu YJ, Root C, Hughes D, del Rio C, Armstrong WS. Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade. Clin Infect Dis. 2016 Mar 1;62(5):648 - 654. PMID 26567263.

Colasanti J, Goswami ND, Khoubian JJ, Pennisi E, Root C, Ziemer D, Armstrong WS, del Rio C. The perilous road from HIV diagnosis in the hospital to viral suppression in the outpatient clinic. AIDS Res Hum Retroviruses 2016; April 15 [Epub ahead of print] PMID 27005488.

Colasanti J, Stahl N, Farber EW, Del Rio C, Armstrong WS. An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS. J Acquir Immune Defic Syndr. 2017 Feb 1;74 Suppl 2:S113-S120. PMID 28079721.

Goswami ND, Colasanti J, Khoubian JJ, Huang Y, Armstrong WS, Del Rio C. A Minority of Patients Newly Diagnosed with AIDS Are Started on Antiretroviral Therapy at the Time of Diagnosis in a Large Public Hospital in the Southeastern United States. J Int Assoc Provid AIDS Care. 2017 Jan 1. PMID 28198210

Sharp J and Colasanti J. The HIV Care Continuum in Atlanta: A Medical Student’s Unique Perspective. SGIM Forum. 2017 June;40(6):5, 13.

Taiwo BO, Marconi VC, Berzins B, Moser CB, Nyaku AN, Fitchenbaum CJ, Benson CA, Wilkin T, Koletar SL, Colasanti J, Acosta EP, Li JZ, Sax PE. Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial. Clin Infect Dis2017 Dec 26. PMID 29293895

Colasanti J, Sumitani J, Mehta CC, Zhang Y, Nguyen ML, del Rio C, Armstrong WS. Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the Southern United States. 5(6) 28 June 2018. PMID: 29992172

Colasanti J, Lira MC, Cheng D, Forman LS, Sullivan M, Root C, Abrams C, Podolsky M, Armstrong WS, Samet J, del Rio, C. Opioid use for Chronic Pain Among Patients with HIV. Clin Infect Dis. 31 May 2018 [epub ahead of print] PMID: 29860411

Colasanti J, Galaviz KI, Mehta CC, Palar K, Schneider MF, Tien P, Adimora AA, Alcaide M, Cohen MH, Gustafson D, Karim R, Merenstein D, Sharma A, Wingood G, Marconi VC, Ofotokun I, Ali MK. Room for improvement: The HIV-Diabetes Care Continuum over 15 years in the Women’s Interagency HIV Study. Open Forum Infect Dis In Press. 5(6) 1 June 2018. PMID 29942823

Carroll, J.J., Colasanti, J., Lira, M.C., del Rio, C., Samet, JH. et al. HIV Physicians and Chronic Opioid Therapy: It’s Time to Raise the Bar. AIDS Behav. 2018. Dec 5 PMID 30519904

Tsui JI, Walley AY, Cheng DM, Lira MC, Liebschutz JM, Forman LS, Sullivan MM, Colasanti J, Root C, O’Connor K, Shanahan CW, Bridden CL, del Rio C, Samet JH. Provider Opioid Prescribing Practices and the Belief that Opioids Keep People Living with HIV Engaged in Care: A Cross-sectional Study. AIDS Care. 2019 Jan 11: 1-5. PMID 30632790

Galaviz KI, Schneider MF, Tien PC, Mehta CC, Ofotokun I, Colasanti J, Marconi VC, Palar K, Wingood G, Adimora AA, Alcaide M, Cohen MH, Gustafson D, Karim R, Konkle-Parker D, Merenstein D, Sharma A, Ali MK. Predicting diabetes risk among HIV-positive and HIV-negative women. AIDS. 2018. Nov 28; 32(18): 2767-2775. PMID 30289812